Bottom line
IYH vs GGHCX: the short answer
IYH (iShares U.S. Healthcare ETF) and GGHCX (INVESCO Health Care Fund) share a meaningful slice of their top holdings — about 52% by weight.
IYH is cheaper at 0.37% vs 1.07% — a difference of $70 a year per $10,000 invested.
Over five years, IYH returned +7.0% a year vs +2.6% for GGHCX.
GGHCX has a front-end sales load of up to 5.5%; the other does not.
Updated Nov 19, 2026
IYH vs GGHCX side by side
| IYH | GGHCX | |
|---|---|---|
| Type | ETF | Mutual fund |
| Fund family | iShares | Invesco |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.37% | 1.07% |
| Annual cost per $10k | $37 | $107 |
| 10-yr cost on $10k (prospectus) | $468 | $1,784 |
| Max front load | None | 5.5% |
| 12b-1 fee | 0% | 0.25% |
| 1-yr return | +13.1% | +9.2% |
| 5-yr return (annualized) | +7.0% | +2.6% |
| 10-yr return (annualized) | +9.4% | +5.8% |
| Best quarter | +15.3% | +19.6% |
| Worst quarter | −12.7% | −16.5% |
| Net assets (fund) | $3.6B | $1.2B |
| Number of holdings | 103 | 82 |
| Portfolio turnover | 3% | 59% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | IYH | GGHCX | Difference |
|---|---|---|---|
| 2025 | +13.1% | +15.5% | −2.4% |
| 2024 | +3.1% | +4.0% | −0.9% |
| 2023 | +2.1% | +3.1% | −1.0% |
| 2022 | −4.4% | −13.5% | +9.2% |
| 2021 | +23.4% | +12.2% | +11.2% |
| 2020 | +15.5% | +14.5% | +1.0% |
| 2019 | +20.8% | +32.0% | −11.2% |
| 2018 | +5.9% | +0.5% | +5.4% |
| 2017 | +22.3% | +15.5% | +6.9% |
| 2016 | −2.8% | −11.7% | +8.9% |
Source: Fund prospectus bar charts
Holdings overlap
9 of IYH's top 25 holdings also appear in GGHCX's top 25.
| Holding | IYH | GGHCX |
|---|---|---|
| Eli Lilly And Company | 15.11% | 10.59% |
| Johnson & Johnson | 10.17% | 6.76% |
| Abbvie Inc. | 7.32% | 4.03% |
| Unitedhealth Group Incorporated | 6.16% | 6.17% |
| Merck & Co., Inc. | 5.31% | 4.59% |
| Thermo Fisher Scientific Incorporated | 3.52% | 1.55% |
| Gilead Sciences, Inc. | 2.66% | 3.63% |
| Vertex Pharmaceuticals Incorporated | 2.00% | 2.01% |
| Edwards Lifesciences Corporation | 0.81% | 1.56% |
Source: SEC Form N-PORT
IYH top 10
- Eli Lilly And Company — 15.11%
- Johnson & Johnson — 10.17%
- Abbvie Inc. — 7.32%
- Unitedhealth Group Incorporated — 6.16%
- Merck & Co., Inc. — 5.31%
- Thermo Fisher Scientific Incorporated — 3.52%
- Amgen Inc. — 3.42%
- Abbott Laboratories — 3.02%
- Gilead Sciences, Inc. — 2.66%
- Pfizer Inc. — 2.35%
GGHCX top 10
- Eli Lilly and Co. — 10.59%
- Johnson & Johnson — 6.76%
- UnitedHealth Group Inc. — 6.17%
- Invesco Private Prime Fund — 4.67%
- Merck & Co., Inc. — 4.59%
- AbbVie Inc. — 4.03%
- Gilead Sciences, Inc. — 3.63%
- argenx SE — 3.24%
- CVS Health Corp. — 2.52%
- Welltower Inc. — 2.34%
FAQ
What is the difference between IYH and GGHCX?
Which is cheaper, IYH or GGHCX?
Should I own both IYH and GGHCX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.